159 related articles for article (PubMed ID: 24668481)
1. Motoneuron disease.
Sendtner M
Handb Exp Pharmacol; 2014; 220():411-41. PubMed ID: 24668481
[TBL] [Abstract][Full Text] [Related]
2. Axonal defects in mouse models of motoneuron disease.
Jablonka S; Wiese S; Sendtner M
J Neurobiol; 2004 Feb; 58(2):272-86. PubMed ID: 14704958
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.
Martin LJ; Chang Q
Mol Neurobiol; 2012 Feb; 45(1):30-42. PubMed ID: 22072396
[TBL] [Abstract][Full Text] [Related]
4. [Motor neuron diseases. Present].
Pou A
Neurologia; 1996 Dec; 11 Suppl 5():1-6. PubMed ID: 9044569
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development.
Bowerman M; Murray LM; Scamps F; Schneider BL; Kothary R; Raoul C
Eur J Med Genet; 2018 Nov; 61(11):685-698. PubMed ID: 29313812
[TBL] [Abstract][Full Text] [Related]
6. The Actin Cytoskeleton in SMA and ALS: How Does It Contribute to Motoneuron Degeneration?
Hensel N; Claus P
Neuroscientist; 2018 Feb; 24(1):54-72. PubMed ID: 28459188
[TBL] [Abstract][Full Text] [Related]
7. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
8. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
[TBL] [Abstract][Full Text] [Related]
9. Fasciculation discharge frequency in amyotrophic lateral sclerosis and related disorders.
de Carvalho M; Swash M
Clin Neurophysiol; 2016 May; 127(5):2257-62. PubMed ID: 27072098
[TBL] [Abstract][Full Text] [Related]
10. Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice.
Locatelli F; Corti S; Papadimitriou D; Fortunato F; Del Bo R; Donadoni C; Nizzardo M; Nardini M; Salani S; Ghezzi S; Strazzer S; Bresolin N; Comi GP
Ann Neurol; 2007 Jul; 62(1):81-92. PubMed ID: 17503505
[TBL] [Abstract][Full Text] [Related]
11. Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice.
Kuo JJ; Schonewille M; Siddique T; Schults AN; Fu R; Bär PR; Anelli R; Heckman CJ; Kroese AB
J Neurophysiol; 2004 Jan; 91(1):571-5. PubMed ID: 14523070
[TBL] [Abstract][Full Text] [Related]
12. Stress signaling from the endoplasmic reticulum: A central player in the pathogenesis of amyotrophic lateral sclerosis.
Walker AK; Atkin JD
IUBMB Life; 2011 Sep; 63(9):754-63. PubMed ID: 21834058
[TBL] [Abstract][Full Text] [Related]
13. Underediting of GluR2 mRNA, a neuronal death inducing molecular change in sporadic ALS, does not occur in motor neurons in ALS1 or SBMA.
Kawahara Y; Sun H; Ito K; Hideyama T; Aoki M; Sobue G; Tsuji S; Kwak S
Neurosci Res; 2006 Jan; 54(1):11-4. PubMed ID: 16225946
[TBL] [Abstract][Full Text] [Related]
14. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
[TBL] [Abstract][Full Text] [Related]
15. Prolonged survival and milder impairment of motor function in the SOD1 ALS mouse model devoid of fibroblast growth factor 2.
Thau N; Jungnickel J; Knippenberg S; Ratzka A; Dengler R; Petri S; Grothe C
Neurobiol Dis; 2012 Aug; 47(2):248-57. PubMed ID: 22542539
[TBL] [Abstract][Full Text] [Related]
16. Motoneuron cell death and neurotrophic factors: basic models for development of new therapeutic strategies in ALS.
Beck M; Karch C; Wiese S; Sendtner M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S55-68. PubMed ID: 11465926
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.
Pitzer C; Krüger C; Plaas C; Kirsch F; Dittgen T; Müller R; Laage R; Kastner S; Suess S; Spoelgen R; Henriques A; Ehrenreich H; Schäbitz WR; Bach A; Schneider A
Brain; 2008 Dec; 131(Pt 12):3335-47. PubMed ID: 18835867
[TBL] [Abstract][Full Text] [Related]
18. Molecular approaches to amyotrophic lateral sclerosis.
Smith RG; Appel SH
Annu Rev Med; 1995; 46():133-45. PubMed ID: 7598450
[TBL] [Abstract][Full Text] [Related]
19. Corticomotoneuronal integrity and adaptation in spinal muscular atrophy.
Farrar MA; Vucic S; Johnston HM; Kiernan MC
Arch Neurol; 2012 Apr; 69(4):467-73. PubMed ID: 22491191
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms for axon maintenance and plasticity in motoneurons: alterations in motoneuron disease.
Jablonka S; Dombert B; Asan E; Sendtner M
J Anat; 2014 Jan; 224(1):3-14. PubMed ID: 24007389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
